RetinalGenix Technologies (RTGN) Non-Current Assets (2022 - 2026)
RetinalGenix Technologies (RTGN) posted Non-Current Assets of $5625.0 for Q1 2026, down 10.24% sequentially from $6267.0 in Q4 2025, and down 31.57% YoY from $8220.0 in Q1 2025.
RetinalGenix Technologies (RTGN) Non-Current Assets (2022 - 2026) Analysis & Trends
RetinalGenix Technologies has reported Non-Current Assets for 5 years, with the latest figure at $5625.0 in Q1 2026.
- Quarterly Non-Current Assets fell 31.57% year-over-year to $5625.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26350.0 (down 2.32% YoY) and the FY2025 annual result came in at $6267.0, down 29.47% from the prior year.
- Non-Current Assets retreated to $5625.0 in Q1 2026 per RTGN's latest filing, from $6267.0 in the prior quarter.
- Over five years, Non-Current Assets peaked at $9765.0 in Q3 2024 and troughed at $106.0 in Q2 2024.
- A 5-year average of $3651.3 and a median of $282.0 in 2022 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2024 and 2025: Non-Current Assets sank 48.54% in 2024, then soared 7021.7% in 2025.
- Over 5 years, Non-Current Assets stood at $256.0 in 2022, then slumped by 39.06% to $156.0 in 2023, then jumped by 5596.15% to $8886.0 in 2024, then declined by 29.47% to $6267.0 in 2025, then declined by 10.24% to $5625.0 in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $5625.0, $6267.0, and $6909.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.20 Bn | 193.60 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 127.66 Bn | 124.19 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.37 Bn | 32.42 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.89 Bn | 31.78 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 8.29 Bn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | 5,625.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,625.00 |
| Dec 31, 2025 | 6,267.00 |
| Sep 30, 2025 | 6,909.00 |
| Jun 30, 2025 | 7,549.00 |
| Mar 31, 2025 | 8,220.00 |
| Dec 31, 2024 | 8,886.00 |
| Sep 30, 2024 | 9,765.00 |
| Jun 30, 2024 | 106.00 |
| Mar 31, 2024 | 131.00 |
| Dec 31, 2023 | 156.00 |
| Sep 30, 2023 | 181.00 |
| Jun 30, 2023 | 206.00 |
| Mar 31, 2023 | 231.00 |
| Dec 31, 2022 | 256.00 |
| Sep 30, 2022 | 282.00 |